Advertisement

Pediatric Cardiology

, Volume 39, Issue 4, pp 743–748 | Cite as

Age-Dependent Association Between Pre-transplant Blood Transfusion and Outcomes of Pediatric Heart Transplantation

  • C. McKee
  • D. Tumin
  • B. R. Alevriadou
  • K. K. Nicol
  • A. R. Yates
  • D. HayesJr.
  • J. D. Tobias
Original Article
  • 139 Downloads

Abstract

Avoidance of red blood cell (RBC) transfusions in patients awaiting heart transplantation (HTx) has been suggested to minimize the risk of allosensitization. Although recent studies have suggested that an immature immune system in younger HTx recipients may reduce risks associated with RBC transfusion, the role of age in moderating the influence of transfusion on HTx outcomes remains unclear. We used available data from a national transplant registry to explore whether the association between pre-transplant transfusions and outcomes of pediatric HTx varies by patient age. De-identified data were obtained from the United Network for Organ Sharing registry, including first-time recipients of isolated HTx performed at age 0–17 years in 1995–2015. The primary exposure was receiving blood transfusions within 2 weeks prior to HTx. Patient survival after HTx was evaluated using multivariable Cox proportional hazards, where age at transplant was interacted with exposure to pre-transplant transfusion. Age-specific hazard ratios (HRs) of pre-transplant transfusion were plotted across ages at transplant. There were 4883 patients meeting inclusion criteria, of whom 1258 died during follow-up (mean follow-up duration 6 ± 5 years). Patients receiving pre-transplant transfusions were distinguished by younger age, higher prevalence of prior cardiac surgery, greater likelihood of being in the intensive care unit, and greater use of left ventricular assist device bridge to transplant. In multivariable analysis, pre-transplant transfusions were associated with increased mortality hazard among infants < 1 year of age (HR = 1.46; 95% CI 1.23, 1.74; p < 0.001). For each additional year of age, the excess hazard associated with pre-transplant transfusions decreased by 3% (interaction HR = 0.97; 95% CI 0.98, 0.99; p = 0.003). By age 8, the association between pre-transplant transfusions and post-transplant mortality was no longer statistically significant (HR = 1.15; 95% CI 0.99, 1.32; p = 0.060). Pre-transplant transfusions were associated with increased mortality hazard only among younger children (age < 8 years) undergoing HTx. These data support the current practices of transfusion avoidance prior to HTx, particularly in younger patients.

Keywords

Blood transfusion Pediatric Heart transplantation Cardiac intensive care 

Notes

Author Contributions

CM assisted with study design and manuscript drafting and revision. DT assisted with statistical analysis and manuscript drafting. BRA provided initial study concept and assisted with manuscript revision. KKN provided initial study concept and critical revision of manuscript. ARY provided initial study concept and critical revision of manuscript. DHJ assisted with study design and manuscript drafting and revision. JDT assisted with study design and manuscript revision. All authors approved of the final version of this manuscript.

Compliance with Ethical Standards

Conflict of interest

Christopher McKee, Dmitry Tumin, B. Rita Alevriadou, Kathleen K. Nicol, Andrew R. Yates, Don Hayes Jr., Joseph D. Tobias declares that they have no conflict of interest.

Ethical Approval

This article does not contain any studies with human participants or animals performed by any of the authors. The study was deemed exempt from review by the Institutional Review Board at Nationwide Children’s Hospital.

References

  1. 1.
    Scornik JC, Meier-Kriesche HU (2011) Blood transfusions in organ transplant patients: mechanisms of sensitization and implications for prevention. Am J Transplant 11(9):1785–1791CrossRefPubMedGoogle Scholar
  2. 2.
    Vanderlaan RD, Manlhiot C, Edwards LB, Conway J, McCrindle BW, Dipchand AI (2015) Risk factors for specific causes of death following pediatric heart transplant: an analysis of the registry of the International Society of Heart and Lung Transplantation. Pediatr Transplant 19(8):896–905CrossRefPubMedGoogle Scholar
  3. 3.
    Morris AA, Cole RT, Veledar E, Bellam N, Laskar SR, Smith AL, Gebel HM, Bray RA, Butler J (2013) Influence of race/ethnic differences in pre-transplantation panel reactive antibody on outcomes in heart transplant recipients. J Am Coll Cardiol 62(24):2308–2315CrossRefPubMedGoogle Scholar
  4. 4.
    Carter HF, Lau C, Juma D, Wells B, Applegate RL 2nd (2016) Intraoperative red blood cell transfusion in infant heart transplant patients is not associated with worsened outcomes. Anesth Analg 122(5):1567–1577CrossRefPubMedGoogle Scholar
  5. 5.
    Howard-Quijano K, Schwarzenberger JC, Scovotti JC, Alejos A, Ngo J, Gornbein J, Mahajan A (2013) Increased red blood cell transfusions are associated with worsening outcomes in pediatric heart transplant patients. Anesth Analg 116(6):1295–1308CrossRefPubMedGoogle Scholar
  6. 6.
    DiNardo JA, Faraoni D (2016) Red blood cell transfusion and massive bleeding in children undergoing heart transplant. Anesth Analg 122(5):1245–1246CrossRefPubMedGoogle Scholar
  7. 7.
    United Network for Organ Sharing/Organ Procurement and Transplantation Network. Standard Transplant Analysis and Research Database. http://optn.transplant.hrsa.gov/data/about/OPTNDatabase.asp. Accessed 25 Sept 2015
  8. 8.
    Sheikh SI, Hayes D Jr, Kirkby SE, Tobias JD, Tumin D (2017) Age-dependent gender disparities in post lung transplant survival among patients with idiopathic pulmonary fibrosis. Ann Thorac Surg 103:441–446CrossRefPubMedGoogle Scholar
  9. 9.
    McKee C, Tumin D, Hayes D Jr, Tobias JD (2016) The impact of length and weight on survival after heart transplantation in children less than 24 months of age. Pediatr Transplant 20(8):1098–1105CrossRefPubMedGoogle Scholar
  10. 10.
    Picascia A, Grimaldi V, Infante T, Maiello C, Crudele V et al (2012) Current concepts in histocompatibility during heart transplant. Exp Clin Transplant 10(3):209–218CrossRefPubMedGoogle Scholar
  11. 11.
    Hyun J, Park KD, Yoo Y, Lee B, Han BY et al (2012) Effects of different sensitization events on HLA alloimmunization in solid organ transplantation patients. Transplant Proc 44(1):222–225CrossRefPubMedGoogle Scholar
  12. 12.
    Bhaskar B, Dulhunty J, Mullany D, Fraser J (2012) Impact of blood product transfusion on short and long-term survival after cardiac surgery: more evidence. Ann Thorac Surg 94:460–467CrossRefPubMedGoogle Scholar
  13. 13.
    Vamvakas E, Blajchman M (2007) Transfusion-related immunomodulation (TRIM): an update. Blood Rev 21:327–348CrossRefPubMedGoogle Scholar
  14. 14.
    Hayes D Jr, Tumin D, Yates A, Mansour H, Nicol K et al (2016) Transfusion with packed red blood cells while awaiting lung transplantation is associated with reduced survival after lung transplantation. Clin Transpl 30:1545–1551CrossRefGoogle Scholar
  15. 15.
    Opelz G, Vanrenterghem Y, Kirste G, Gray DW, Horsburgh T, Lachance JG, Largiader F, Lange H, Vujaklija-Stipanovic K, Alvarez-Grande J, Schott W, Hoyer J, Schnuelle P, Descoeudres C, Ruder H, Wujciak T, Schwarz V (1997) Prospective evaluation of pretransplant blood transfusions in cadaver kidney recipients. Transplantation 63(7):964–967CrossRefPubMedGoogle Scholar
  16. 16.
    Vamvakas EC, Blajchman MA (2007) Transfusion-related immunomodulation (TRIM): an update. Blood Rev 21(6):327–348CrossRefPubMedGoogle Scholar
  17. 17.
    van de Watering LM, Hermans J, Houbiers JG, van den Broek PJ, Bouter H, Boer F, Harvey MS, Huysmans HA, Brand A (1998) Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial. Circulation 97(6):562–568CrossRefPubMedGoogle Scholar
  18. 18.
    Wypij D, Jonas R, Bellinger D, Del Nido P, Mayer J et al (2008) The effect of hematocrit during hypothermic cardiopulmonary bypass in infant heart surgery: results from the combined boston hematocrit trials. J Thorac Cardiovasc Surg 135(2):355–360CrossRefPubMedGoogle Scholar
  19. 19.
    Sebastian R, Ratilff T, Winch PD, Tumin D, Gomez D et al (2017) Revisiting acute normovolemic hemodilution and blood transfusion during pediatric cardiac surgery: a prospective observational study. Paediatr Anaesth 27(1):85–90CrossRefPubMedGoogle Scholar
  20. 20.
    Likosky D, Dickinson T, Paugh T (2016) Blood conservation—a team sport. J Extra Corpor Technol 48(3):99–104PubMedPubMedCentralGoogle Scholar
  21. 21.
    Cladellas M, Farre N, Comin-Colet J, Gomez M, Merono O, Bosch A et al (2012) Effects of preoperative intravenous erythropoietin plus iron on outcome in anemic patients after cardiac valve replacement. Am J Cardiol 110(7):1021–1026CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Anesthesiology and Pain MedicineNationwide Children’s HospitalColumbusUSA
  2. 2.Department of PediatricsNationwide Children’s HospitalColumbusUSA
  3. 3.Departments of Biomedical Engineering and Internal MedicineThe Ohio State UniversityColumbusUSA
  4. 4.Department of PathologyNationwide Children’s HospitalColumbusUSA

Personalised recommendations